Vergenix STR
-
Financial
CollPlant Signs Exclusive Distribution Agreement with Arthrex for Vergenix™STR
NESS ZIONA, Israel, November 8, 2016 /PRNewswire/ — CollPlant Ltd. (TASE: CLPT), a regenerative medicine company utilizing its proprietary plant-based recombinant human collagen (rhCollagen)…
Read More » -
Hospitals
CollPlant Receives CE Mark for Vergenix™STR for Treatment of Tendinopathy
NESS ZIONA, Israel, October 19, 2016 /PRNewswire/ — CollPlant (TASE: CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen (recombinant human collagen) technology…
Read More » -
Hospitals
CollPlant Reports Positive Final Extended Clinical Trial Results with Vergenix™STR for Treatment of Tendinopathy
Ness Ziona, Israel, August 17, 2016 – CollPlant Ltd. (TASE: CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen…
Read More » -
Recon
CollPlant Reports Positive Interim Trial Results for Vergenix™STR, Indicated for the Treatment of Tendinopathy
CollPlant Ltd. (TASE:CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products, today announced positive…
Read More » -
Biologics
CollPlant Reports Positive Interim Trial Results
CollPlant Ltd. (TASE:CLPT; OTC:CQPTY), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products, today announced…
Read More »